In vivo, oncology, immuno-oncology, efficacy evaluation, chick embryo model, toxicity, target validation

INOVOTION is a biotech company which offers you a unique in vivo technology to evaluate efficacy and toxicity of treatment in oncology and immuno-oncology.

Our Fast, Sensitive, Reliable and Affordable in vivo assay will save you time and money, to give you a clear competitive advantage.
This breaking-thought technology, based on chick embryo, provides early analysis of your treatments before the classical preclinical stages. By eliminating low-value molecules early, INOVOTION accelerates your drug discovery process, increases your R&D productivity and reduces its costs.

• This next generation of in vivo assay covers fours main aspects:
• Efficacy of your oncology and IO treatments
• Toxicity for all your candidate compounds
• Target Validation in oncology
• Multi-Cancer Screening to (re)positioning your drugs